Haemonetics Fair Value
HA
The fair market value of HAE stock is 109.94 USD. Relative to the market price of 75.44 USD Haemonetics is undervalued by 45.7%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Haemonetics Valuation
Current HAE share ticker price is 75.44 USD.
The fair value level of 109.94 USD can be considered as an effective entry point for long-term investors to start investing in HAE stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 46% lower its fair value
Current price is 12% lower its minimum value
Current price is 140% lower its maximum value
Market price:
HAE stock is greatly undervalued
It means the current price may concern as a Low Risk Entry Point
Haemonetics Corp Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
74.55
2
Median P/E over 5 years
45.2
3
Minimum P/E over 5 years
34.86
4
Earning per share (last 12 months)
2.43 USD
Maximum value
1
x
4
=
181.34 USD
Fair value
2
x
4
=
109.94 USD
Minimum value
3
x
4
=
84.8 USD
Haemonetics Corp price metrics
-7.21
Annual return (geometric mean)
44.74
Risk (standard deviation) of returns
β
0.42
Beta (volatility compared to market)